Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anterix (ATEX) Research & Development (2016 - 2025)

Anterix's Research & Development history spans 13 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Research & Development fell 1.43% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $4.5 million, down 34.32%, while the annual FY2025 figure was $5.7 million, 0.67% up from the prior year.
  • Research & Development reached $1.1 million in Q4 2025 per ATEX's latest filing, down from $1.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $2.2 million in Q1 2024 to a low of $767000.0 in Q1 2022.
  • Average Research & Development over 5 years is $1.2 million, with a median of $1.1 million recorded in 2024.
  • Peak YoY movement for Research & Development: soared 86.05% in 2023, then tumbled 51.45% in 2025.
  • A 5-year view of Research & Development shows it stood at $893000.0 in 2021, then increased by 4.82% to $936000.0 in 2022, then skyrocketed by 32.26% to $1.2 million in 2023, then dropped by 9.53% to $1.1 million in 2024, then fell by 1.43% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for ATEX's Research & Development are $1.1 million (Q4 2025), $1.2 million (Q3 2025), and $1.1 million (Q2 2025).